Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dalfampridine[1] Dalfampridine[1] Dalfampridine 💬 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬 		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 4, 13 💬
2Daraprim[1] Pyrimethamine[1] Pyrimethamine 💬 --[2] 2, 4 💬
3Dexdor[1] Dexmedetomidine[2] Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[4] 2, 4, 6, 70 💬
4Dexmedetomidine[1] Dexmedetomidine[2] Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[15] 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
5Esketamine[1] Esketamine[2] Esketamine ,
Esketamine hydrochloride 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[5] 2, 4, 6, 96, 97 💬
6HB-admscs[1] Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---[7] 2, 4, 6, 13, 14, 46, 49 💬
7Ketanest-S----[3] 2, 4, 70 💬
8Levetiracetam[1] Levetiracetam[1] Levetiracetam 💬 [1] SV2 💬 [1] ECM-receptor interaction 💬[7] 2, 4, 6, 13, 34, 149, 307 💬
9Pyrimethamine[1] Pyrimethamine[1] Pyrimethamine 💬 --[4] 2, 4, 19, 65 💬
10Stem cells----[5] 2, 4, 46, 96, 113 💬